Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Aging Cell|December 18, 2013
Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restrictionRichard A Miller, David E Harrison, Clinton M Astle, et al.
Aging Cell|November 20, 2013
Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in malesDavid E Harrison, Randy Strong, David B Allison, et al.
Experimental Gerontology|June 28, 2008
Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf miceJ McKee Alderman, Kevin Flurkey, Natasha L Brooks, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 27, 2010
Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous miceRichard A Miller, David E Harrison, C M Astle, et al.
Aging Cell|March 31, 2021
17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sexDavid E Harrison, Randy Strong, Peter Reifsnyder, et al.
Aging Cell|January 29, 2019
Acarbose improves health and lifespan in aging HET3 miceDavid E Harrison, Randy Strong, Silvestre Alavez, et al.
Aging Cell|June 18, 2016
Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducerRandy Strong, Richard A Miller, Adam Antebi, et al.
Geroscience|December 2, 2023
Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules usedDavid E Harrison, Randy Strong, Peter Reifsnyder, et al.
Pageof 4